DK1071745T3 - Fremgangsmåde til syntetisering af COX-2-inhibitorer - Google Patents
Fremgangsmåde til syntetisering af COX-2-inhibitorerInfo
- Publication number
- DK1071745T3 DK1071745T3 DK99918706T DK99918706T DK1071745T3 DK 1071745 T3 DK1071745 T3 DK 1071745T3 DK 99918706 T DK99918706 T DK 99918706T DK 99918706 T DK99918706 T DK 99918706T DK 1071745 T3 DK1071745 T3 DK 1071745T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitors
- cox
- synthesizing
- synthesizing cox
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/30—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having nitrogen atoms of imino groups quaternised
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8288898P | 1998-04-24 | 1998-04-24 | |
| US8566898P | 1998-05-15 | 1998-05-15 | |
| EP99918706A EP1071745B1 (fr) | 1998-04-24 | 1999-04-20 | Procede de synthese d'inhibiteurs de cox-2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1071745T3 true DK1071745T3 (da) | 2004-11-29 |
Family
ID=26767964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99918706T DK1071745T3 (da) | 1998-04-24 | 1999-04-20 | Fremgangsmåde til syntetisering af COX-2-inhibitorer |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US6040319A (fr) |
| EP (1) | EP1071745B1 (fr) |
| JP (2) | JP3325264B2 (fr) |
| KR (1) | KR100414998B1 (fr) |
| CN (1) | CN1178658C (fr) |
| AR (1) | AR015279A1 (fr) |
| AT (1) | ATE272613T1 (fr) |
| AU (1) | AU759469B2 (fr) |
| BR (2) | BRPI9917739B8 (fr) |
| CA (1) | CA2329193C (fr) |
| CZ (1) | CZ292515B6 (fr) |
| DE (1) | DE69919151T2 (fr) |
| DK (1) | DK1071745T3 (fr) |
| EA (1) | EA002975B1 (fr) |
| ES (1) | ES2226378T3 (fr) |
| HK (1) | HK1031399A1 (fr) |
| HR (1) | HRP20000722B1 (fr) |
| HU (1) | HU227627B1 (fr) |
| IL (2) | IL139127A0 (fr) |
| NZ (1) | NZ507597A (fr) |
| PL (1) | PL193248B1 (fr) |
| PT (1) | PT1071745E (fr) |
| RS (1) | RS49945B (fr) |
| SI (1) | SI1071745T1 (fr) |
| SK (1) | SK284805B6 (fr) |
| TW (1) | TW474934B (fr) |
| UA (1) | UA57143C2 (fr) |
| WO (1) | WO1999055830A2 (fr) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5861419A (en) * | 1996-07-18 | 1999-01-19 | Merck Frosst Canad, Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| KR100446324B1 (ko) | 1999-01-14 | 2004-08-30 | 론자 아게 | 1-(6-메틸피리딘-3-일)-2-[4-(메틸술포닐)페닐]에타논 및이의 제조 방법 |
| DE50004327D1 (de) * | 1999-01-14 | 2003-12-11 | Lonza Ag | Verfahren zur herstellung von 1-(6-methylpyridin-3-yl)-2- 4-(methylsulfonyl phenyl)ethanon |
| JP2001115963A (ja) | 1999-10-13 | 2001-04-27 | Daikin Ind Ltd | 圧縮機 |
| US6858631B1 (en) | 1999-11-29 | 2005-02-22 | Merck & Co., Inc. | Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl |
| CA2391650C (fr) * | 1999-11-29 | 2011-01-25 | Merck & Co., Inc. | Formes polymorphes, amorphes et hydratees de 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyle |
| NZ513960A (en) * | 1999-12-08 | 2004-02-27 | Pharmacia Corp | Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| JP2001261653A (ja) * | 2000-03-17 | 2001-09-26 | Sankio Chemical Co Ltd | ピリジン誘導体の合成法 |
| PH12001001175B1 (en) * | 2000-05-26 | 2006-08-10 | Merck Sharp & Dohme | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- (2,3')bipyridinyl in pure crystalline form and process for synthesis |
| US6521642B2 (en) | 2000-05-26 | 2003-02-18 | Merck & Co., Inc. | 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis |
| US6800647B2 (en) | 2000-05-26 | 2004-10-05 | Merck & Co., Inc. | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3]bipyridinyl in pure crystalline form and process for synthesis |
| CA2414674A1 (fr) * | 2000-07-13 | 2002-01-24 | Pharmacia Corporation | Utilisation d'inhibiteurs de cox-2 pour le traitement et la prevention de troubles oculaires a mediation cox-2 |
| PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
| US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| MY137736A (en) | 2001-04-03 | 2009-03-31 | Pharmacia Corp | Reconstitutable parenteral composition |
| US20040132780A1 (en) * | 2001-05-04 | 2004-07-08 | Allen Christopher P. | Method and compositions for treating migraines |
| UA80682C2 (en) * | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
| JP4700916B2 (ja) * | 2004-02-02 | 2011-06-15 | 富士フイルムファインケミカルズ株式会社 | ピリジン誘導体の製造方法 |
| US7271383B2 (en) * | 2004-08-11 | 2007-09-18 | Lexmark International, Inc. | Scanning system with feedback for a MEMS oscillating scanner |
| US20080096927A1 (en) | 2004-08-24 | 2008-04-24 | Simon Thomas J | Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events |
| CA2676413A1 (fr) * | 2007-01-19 | 2008-07-31 | Mallinckrodt Inc. | Ligands de liaison a la cycloxygenase-2 diagnostiques et therapeutiques |
| ES2562981T3 (es) | 2009-02-27 | 2016-03-09 | Cadila Healthcare Limited | Un procedimiento para la preparación de Etoricoxib |
| ES2683125T3 (es) | 2010-06-16 | 2018-09-25 | Glenmark Generics Limited | Proceso para la preparación de piridinas 2,3-diaril-5-sustituidas y sus compuestos intermedios |
| EP2649049B1 (fr) | 2010-11-15 | 2016-08-24 | Virdev Intermediates Pvt. Ltd. | Procédé pour la préparation de l'etoxicorib |
| ITMI20110362A1 (it) | 2011-03-09 | 2012-09-10 | F I S Fabbrica Italiana Sint P A | Procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib. |
| EP2714676B1 (fr) | 2011-05-27 | 2019-04-24 | Farma GRS, d.o.o. | Procédé pour la préparation de la forme polymorphe i de l'étoricoxib |
| ITMI20111455A1 (it) | 2011-07-29 | 2013-01-30 | Italiana Sint Spa | Nuovo procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib. |
| CN103204803A (zh) | 2012-01-13 | 2013-07-17 | 阿尔弗雷德·E·蒂芬巴赫尔有限责任两合公司 | 用于合成依托考昔的方法 |
| ITMI20120394A1 (it) | 2012-03-14 | 2013-09-15 | Zach System Spa | Processo di sintesi di un chetosolfone derivato |
| EP2831045A2 (fr) | 2012-03-30 | 2015-02-04 | Mylan Laboratories, Limited | Procédé amélioré pour la préparation d'étoricoxib |
| GR1007973B (el) * | 2012-06-26 | 2013-09-12 | Φαρματεν Αβεε, | Νεα ν-οξοιμινο παραγωγα ως ενδιαμεσα μιας βελτιωμενης μεθοδου παρασκευης 2,3-διαρυλο-5-υποκατεστημενων πυριδινων |
| HUE033525T2 (en) | 2012-08-27 | 2017-12-28 | Cadila Healthcare Ltd | Pharmaceuticals containing Etoricoxib |
| ITVI20130014A1 (it) | 2013-01-22 | 2014-07-23 | Italiana Sint Spa | Procedimento molto efficiente per preparare un intermedio di etoricoxib |
| WO2014114352A1 (fr) * | 2013-01-25 | 2014-07-31 | Synthon Bv | Procédé de préparation d'étoricoxib |
| CN104418799A (zh) * | 2013-09-03 | 2015-03-18 | 天津药物研究院 | 一种依托考昔的晶型及其制备方法和应用 |
| WO2015036550A1 (fr) | 2013-09-13 | 2015-03-19 | Synthon B.V. | Procédé pour la préparation d'étoricoxib |
| US10500178B2 (en) | 2015-03-13 | 2019-12-10 | The Board Of Trustees Of The Leland Stanford Junior University | LTB4 inhibition to prevent and treat human lymphedema |
| CN104817473A (zh) * | 2015-03-27 | 2015-08-05 | 南京大学 | 1-二甲氨基-3-二甲亚胺基-2-氯丙烯高氯酸盐在制备依托考昔中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA988522A (en) * | 1972-05-05 | 1976-05-04 | Haydn W.R. Williams | 1,8-naphthyridine compounds |
| DE3842062A1 (de) * | 1988-12-14 | 1990-06-28 | Hoechst Ag | Explosionssichere 1-dimethylamino-3-dimethylimino-2-arylpropen-1-salze, verfahren zu ihrer herstellung und ihre verwendung |
| BRPI9710372B8 (pt) * | 1996-07-18 | 2021-05-25 | Merck Canada Inc | composto, e, composição farmacêutica. |
| US5861419A (en) * | 1996-07-18 | 1999-01-19 | Merck Frosst Canad, Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
-
1999
- 1999-04-20 BR BRPI9917739A patent/BRPI9917739B8/pt not_active IP Right Cessation
- 1999-04-20 PT PT99918706T patent/PT1071745E/pt unknown
- 1999-04-20 CA CA002329193A patent/CA2329193C/fr not_active Expired - Lifetime
- 1999-04-20 DK DK99918706T patent/DK1071745T3/da active
- 1999-04-20 WO PCT/US1999/008645 patent/WO1999055830A2/fr active IP Right Grant
- 1999-04-20 SK SK1589-2000A patent/SK284805B6/sk not_active IP Right Cessation
- 1999-04-20 RS YUP-641/00A patent/RS49945B/sr unknown
- 1999-04-20 JP JP2000545976A patent/JP3325264B2/ja not_active Expired - Lifetime
- 1999-04-20 DE DE69919151T patent/DE69919151T2/de not_active Expired - Lifetime
- 1999-04-20 HU HU0101407A patent/HU227627B1/hu unknown
- 1999-04-20 IL IL13912799A patent/IL139127A0/xx active IP Right Grant
- 1999-04-20 AT AT99918706T patent/ATE272613T1/de active
- 1999-04-20 EP EP99918706A patent/EP1071745B1/fr not_active Expired - Lifetime
- 1999-04-20 AU AU36557/99A patent/AU759469B2/en not_active Expired
- 1999-04-20 CZ CZ20003940A patent/CZ292515B6/cs not_active IP Right Cessation
- 1999-04-20 KR KR10-2000-7011764A patent/KR100414998B1/ko active Protection Beyond IP Right Term
- 1999-04-20 PL PL344108A patent/PL193248B1/pl unknown
- 1999-04-20 CN CNB998075507A patent/CN1178658C/zh not_active Expired - Lifetime
- 1999-04-20 EA EA200001102A patent/EA002975B1/ru not_active IP Right Cessation
- 1999-04-20 ES ES99918706T patent/ES2226378T3/es not_active Expired - Lifetime
- 1999-04-20 NZ NZ507597A patent/NZ507597A/xx not_active IP Right Cessation
- 1999-04-20 BR BRPI9909844-0A patent/BR9909844B1/pt not_active IP Right Cessation
- 1999-04-20 SI SI9930632T patent/SI1071745T1/xx unknown
- 1999-04-20 UA UA2000116652A patent/UA57143C2/uk unknown
- 1999-04-23 US US09/298,127 patent/US6040319A/en not_active Expired - Lifetime
- 1999-04-23 AR ARP990101884A patent/AR015279A1/es active IP Right Grant
- 1999-04-23 TW TW088106545A patent/TW474934B/zh active
-
2000
- 2000-01-21 US US09/488,774 patent/US6252116B1/en not_active Expired - Fee Related
- 2000-10-18 IL IL139127A patent/IL139127A/en not_active IP Right Cessation
- 2000-10-24 HR HR20000722A patent/HRP20000722B1/xx not_active IP Right Cessation
-
2001
- 2001-03-26 HK HK01102195A patent/HK1031399A1/xx not_active IP Right Cessation
-
2002
- 2002-05-22 JP JP2002147700A patent/JP3834263B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1071745T3 (da) | Fremgangsmåde til syntetisering af COX-2-inhibitorer | |
| DK1016836T3 (da) | Fremgangsmåde til tilvejebringelse af köling | |
| DK1080348T3 (da) | Fremgangsmåde til detektering af farver | |
| FI980464A (fi) | Menetelmä kuvakkeen muodostamiseksi | |
| DK1011309T3 (da) | Fremgangsmåde til tilvejebringelse af forøget fotosyntese | |
| DK1364057T3 (da) | Fremgangsmåde til detektion af ligander | |
| DE69906311D1 (de) | Diarylbenzopyranderivate als cyclooxygenase-2-inhibitoren | |
| DK1083800T3 (da) | Fremgangsmåde til fodring af smågrise | |
| DK0856697T3 (da) | Fremgangsmåde til foring af rør | |
| IS5772A (is) | Þalazín (phthalazine) afleiður af fosfódíesterasa4 lötum | |
| DK1230247T3 (da) | Fremgangsmåde til stabilisering af siloxanforbindelser | |
| NO20010674D0 (no) | Forbedret fremgangsmåte for to-bölgefelts-forsterkning | |
| DK1142990T3 (da) | Fremgangsmåde til fremstilling af transglutaminase | |
| ID28577A (id) | Metoda pemilihan waktu kalibrasi | |
| DK0987356T3 (da) | Fremgangsmåde til trækning | |
| ID27364A (id) | Metode untuk menghambat mrp1 | |
| DK0864564T3 (da) | Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater | |
| DK0749677T3 (da) | Fremgangsmåde til fremskaffelse af data | |
| DK0801070T3 (da) | Fremgangsmåde til fremstilling af platinforbindelse | |
| ID26804A (id) | Metode untuk menghambat mrp1 | |
| DK1053474T3 (da) | Fremgangsmåde til bestemmelse af prostetiske infektioner | |
| DE69931084D1 (de) | Verfahren zur Spurverfolgungsregelung | |
| DK0981950T3 (da) | Fremgangsm,åde til formering af phyllocactus | |
| DK0934786T4 (da) | Fremgangsmåde til strengstøbning af metal samt strengstøbeanlæg hertil | |
| DK1051831T3 (da) | Fremgangsmåde til tilvejebringelse af en adressefortegnelse |